Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7616 | 1268 | 37.3 | 77% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
662 | 12640 | NOCICEPTIN//ORPHANIN FQ//NOCICEPTIN ORPHANIN FQ |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DELTA OPIOID RECEPTOR | Author keyword | 27 | 24% | 8% | 98 |
2 | DELTA OPIOID AGONIST | Author keyword | 21 | 75% | 1% | 15 |
3 | SNC80 | Author keyword | 20 | 57% | 2% | 24 |
4 | NALTRINDOLE | Author keyword | 11 | 23% | 3% | 44 |
5 | CLIN PSYCHOPHARMACOL SECT | Address | 11 | 24% | 3% | 41 |
6 | ADDICT NIH HLTH HUMAN SERV | Address | 11 | 100% | 0% | 6 |
7 | CITDHHS | Address | 9 | 83% | 0% | 5 |
8 | TAN 67 | Author keyword | 9 | 67% | 1% | 8 |
9 | MESSAGE ADDRESS CONCEPT | Author keyword | 8 | 75% | 0% | 6 |
10 | ADDICT SECT | Address | 8 | 60% | 1% | 9 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DELTA OPIOID RECEPTOR | 27 | 24% | 8% | 98 | Search DELTA+OPIOID+RECEPTOR | Search DELTA+OPIOID+RECEPTOR |
2 | DELTA OPIOID AGONIST | 21 | 75% | 1% | 15 | Search DELTA+OPIOID+AGONIST | Search DELTA+OPIOID+AGONIST |
3 | SNC80 | 20 | 57% | 2% | 24 | Search SNC80 | Search SNC80 |
4 | NALTRINDOLE | 11 | 23% | 3% | 44 | Search NALTRINDOLE | Search NALTRINDOLE |
5 | TAN 67 | 9 | 67% | 1% | 8 | Search TAN+67 | Search TAN+67 |
6 | MESSAGE ADDRESS CONCEPT | 8 | 75% | 0% | 6 | Search MESSAGE+ADDRESS+CONCEPT | Search MESSAGE+ADDRESS+CONCEPT |
7 | DELTA OPIOID | 8 | 38% | 1% | 17 | Search DELTA+OPIOID | Search DELTA+OPIOID |
8 | DELTA OPIOID RECEPTORS | 8 | 23% | 2% | 30 | Search DELTA+OPIOID+RECEPTORS | Search DELTA+OPIOID+RECEPTORS |
9 | MORPHINAN | 7 | 44% | 1% | 12 | Search MORPHINAN | Search MORPHINAN |
10 | NALTRIBEN | 7 | 46% | 1% | 11 | Search NALTRIBEN | Search NALTRIBEN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MESSAGE ADDRESS CONCEPT | 123 | 75% | 7% | 89 |
2 | NALTRINDOLE | 109 | 59% | 10% | 121 |
3 | BW373U86 | 85 | 85% | 4% | 45 |
4 | 14 ALKOXYMORPHINANS | 61 | 82% | 3% | 36 |
5 | SNC 80 | 59 | 90% | 2% | 26 |
6 | DIFFERENTIAL ANTAGONISM | 58 | 48% | 7% | 88 |
7 | TAN 67 | 41 | 87% | 2% | 20 |
8 | NALTRINDOLE 5 ISOTHIOCYANATE | 27 | 70% | 2% | 23 |
9 | DEPENDENT BEHAVIORAL STIMULATION | 27 | 92% | 1% | 11 |
10 | 4 ALPHA R ALPHA 2S 5R 4 ALLYL 2 5 DIMETHYL 1 PIPERAZINYL 3 METHOXYBE | 26 | 100% | 1% | 11 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Challenges for opioid receptor nomenclature: IUPHAR Review 9 | 2015 | 17 | 44 | 25% |
Heteromers of mu-delta opioid receptors: new pharmacology and novel therapeutic possibilities | 2015 | 7 | 80 | 50% |
The delta opioid receptor: an evolving target for the treatment of brain disorders | 2011 | 54 | 104 | 50% |
Trafficking of delta-opioid receptors and other G-protein-coupled receptors: implications for pain and analgesia | 2007 | 80 | 91 | 38% |
Recent advances on the delta opioid receptor: from trafficking to function | 2015 | 4 | 240 | 45% |
In vivo opioid receptor heteromerization: where do we stand? | 2015 | 5 | 122 | 37% |
Opioid Ligands with mixed mu/delta opioid receptor interactions: An emerging approach to novel analgesics | 2006 | 43 | 63 | 67% |
Ligand-directed signalling within the opioid receptor family | 2012 | 26 | 92 | 26% |
Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches | 2011 | 23 | 147 | 43% |
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile | 2009 | 51 | 83 | 39% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN PSYCHOPHARMACOL SECT | 11 | 24% | 3.2% | 41 |
2 | ADDICT NIH HLTH HUMAN SERV | 11 | 100% | 0.5% | 6 |
3 | CITDHHS | 9 | 83% | 0.4% | 5 |
4 | ADDICT SECT | 8 | 60% | 0.7% | 9 |
5 | DRUG DESIGN SYNTH SECT | 7 | 35% | 1.3% | 16 |
6 | CHEM BIOL BRANCH | 4 | 15% | 1.8% | 23 |
7 | SEMEL NEUROPSYCHIAT HUMAN BEHAV | 3 | 60% | 0.2% | 3 |
8 | MED CHEM NIH | 2 | 67% | 0.2% | 2 |
9 | UMR CEA 2E | 2 | 67% | 0.2% | 2 |
10 | SHIRLEY STEFAN HATOS NEUROPHARMACOL | 2 | 50% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000227107 | SALVINORIN A//SALVIA DIVINORUM//KAPPA OPIOID RECEPTOR |
2 | 0.0000222523 | DYNORPHIN//CI 977//DYNORPHIN A |
3 | 0.0000208885 | MU OPIOID RECEPTOR//OPIOID RECEPTOR//MOR 1 |
4 | 0.0000205007 | CHEM BIOL PEPTIDE//ENDOMORPHIN 2//ENDOMORPHIN |
5 | 0.0000167506 | DIHYDROETORPHINE//MORPHINE ALKALOIDS//DOPAMINE RECEPTOR ACTIVITY |
6 | 0.0000140715 | OHMEFENTANYL//FENTANYL ANALOGS//4 ANILIDOPIPERIDINES |
7 | 0.0000136160 | TAIL FLICK INHIBITION//BETA ENDORPHIN 1 27//LEUCOPYROKININ |
8 | 0.0000119651 | PHARMACOPERONE//MOL PHARMACOL GRP//BRET |
9 | 0.0000080973 | DRUG DISCRIMINATION//NOVEL RESPONSE PROCEDURE//TRAINING DOSE |
10 | 0.0000070426 | PERIPHERAL OPIOID ANALGESIA//TOPICAL OPIOIDS//KLIN ANAESTHESIOL OPERAT INTENS MED |